/PRNewswire/ Carisma Therapeutics Inc. (Carisma Therapeutics), a clinical stage biopharmaceutical company focused on discovering and developing innovative.
Item 2.02 - Results of Operations and Financial Condition.
On November 7, 2022, Sesen Bio, Inc. announced its financial
results for the quarter ended September 30, 2022. The full text of the. | November 7, 2022
/PRNewswire/ Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national.
/PRNewswire/ Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws.